- €38.04m
- €68.41m
- €118.28m
- 67
- 80
- 53
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.49 | ||
| PEG Ratio (f) | 0.29 | ||
| EPS Growth (f) | 23.81% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.65 | ||
| Price to Tang. Book | 0.81 | ||
| Price to Free Cashflow | 1,021.24 | ||
| Price to Sales | 0.31 | ||
| EV to EBITDA | 4.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.45% | ||
| Return on Equity | 9.45% | ||
| Operating Margin | 7.66% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 73.57 | 76.04 | 81.09 | 97.23 | 118.28 | 121.2 | 139.1 | 11.34% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +26.8 | +1.57 | +24.32 | +14.72 | +33.82 | -2.63 | +23.81 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Svas Biosana SpA is an Italy-based company engaged in manufacturing and distribution of medical devices. The Company has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The Company operates globally.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1992
- Public Since
- December 9th, 2021
- No. of Employees
- 327
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Borsa Italiana- Shares in Issue
- 5,327,890
- Address
- Via Trentola, 7, SOMMA VESUVIANA, 80046
- Web
- http://www.svas.it/
- Phone
- Contact
- Andrea Efficace
- Auditors
- PricewaterhouseCoopers SpA
Upcoming Events for SVS
Dividend For SVSB.MI - 0.2500 EUR
Similar to SVS
Amplifon SpA
Borsa Italiana
DiaSorin SpA
Borsa Italiana
El En SpA
Borsa Italiana
Gvs SpA
Borsa Italiana
IMD International Medical Devices SpA
Borsa Italiana
FAQ
What is the Svas Biosana SpA share price?
As of Today at 23:30 UTC, shares in Svas Biosana SpA are trading at €7.14. This share price information is delayed by 15 minutes.
How has the Svas Biosana SpA share price performed this year?
Shares in Svas Biosana SpA last closed at €7.14 and the price had moved by -12.93% over the past 365 days. In terms of relative price strength the Svas Biosana SpA share price has underperformed the FTSE Global All Cap Index by -15.11% over the past year.
What are the analyst and broker recommendations for Svas Biosana SpA?
The overall consensus recommendation for Svas Biosana SpA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Svas Biosana SpA dividend yield?
The Svas Biosana SpA dividend yield is 4.2% based on the trailing twelve month period.
Does Svas Biosana SpA pay a dividend?
Last year, Svas Biosana SpA paid a total dividend of €0.30, and it currently has a trailing dividend yield of 4.2%.Looking ahead, shares in Svas Biosana SpA are due to go ex-dividend on 2025-06-09 and the next dividend pay date is 2025-06-11.
When does Svas Biosana SpA next pay dividends?
Svas Biosana SpA are due to go ex-dividend on 2025-06-09 and the next dividend pay date is 2025-06-11. The historic dividend yield on Svas Biosana SpA shares is currently 4.2%.
How do I buy Svas Biosana SpA shares?
To buy shares in Svas Biosana SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Svas Biosana SpA?
As of the previous close price of €7.14, shares in Svas Biosana SpA had a market capitalisation of €38.04m.
Where are Svas Biosana SpA shares listed?
Here are the trading details for Svas Biosana SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: SVS
What kind of share is Svas Biosana SpA?
Based on an overall assessment of its quality, value and momentum Svas Biosana SpA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Svas Biosana SpA share price forecast for 2025?
The analyst consensus target price for shares in Svas Biosana SpA is €12.40. That is 73.67% above the last closing price of €7.14.
Analysts covering Svas Biosana SpA currently have a consensus Earnings Per Share (EPS) forecast of €1.05 for the next financial year.
Find out moreWhat is the trend in the Svas Biosana SpA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Svas Biosana SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -4.92%.
As of the last closing price of €7.14, shares in Svas Biosana SpA were trading -5.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Svas Biosana SpA PE Ratio?
The Svas Biosana SpA PE ratio based on its reported earnings over the past 12 months is 5.49. The shares last closed at €7.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Svas Biosana SpA?
We do not have data on Svas Biosana SpA's directors